Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00177_DB06210_nanopub.RAqoh38x2S_upBd_8qjpc5CVtOVgX_HW7pc5JeeWnYlTQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00177_DB06210 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00177_DB06210 label "DDI between Valsartan and Eltrombopag - Eltrombopag may increase the therapeutic and/or toxic effects of Valsartan. Increased Valsartan serum concentrations may be caused by inhibition of hepatic uptake and decreased metabolism. Consider dose modification, alternate therapy or monitor for changes in the therapeutic and toxic effects of Valsartan if Eltrombopag is initiated, discontinued or dose changed. [drugbank_resource:DB00177_DB06210]" assertion.
- drugbank_resource:DB00177_DB06210 identifier "drugbank_resource:DB00177_DB06210" assertion.
- drugbank_resource:DB00177_DB06210 title "DDI between Valsartan and Eltrombopag - Eltrombopag may increase the therapeutic and/or toxic effects of Valsartan. Increased Valsartan serum concentrations may be caused by inhibition of hepatic uptake and decreased metabolism. Consider dose modification, alternate therapy or monitor for changes in the therapeutic and toxic effects of Valsartan if Eltrombopag is initiated, discontinued or dose changed." assertion.
- drugbank:DB00177 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00177_DB06210 assertion.
- drugbank:DB06210 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00177_DB06210 assertion.